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a healthy cartilage tissue requires the sustained function of many
cellular processes and any decline in performance may weaken the
tissue and lead to pathology. These changes may arise because of
inherited susceptibilities and their interaction with environmental
challenges, such as trauma, obesity and ageing.
There is much evidence that many changes occur in chondrocytes
during ageing. In OA there is evidence of an age-related increase in ER
stress, which may mark a decline in secretary pathway function in
chondrocytes and could restrict their ability to maintain the tissue.
There is also evidence of increased apoptosis in OA, which may suggest
that there is an age-related decline in chondrocyte threshold for
survival. This may extend to pathways, such as those involving DNA
repair, resistance to oxidative stress, which may result in accumulated
DNA and protein damage. It may also apply to new areas of chondrocyte
biology, such as circadian clock genes, which have been detected in
chondrocytes (Boot-Handford, Qing-jun Meng, personal communica-
tion). Many circadian clocks in other biological systems show age-
related changes and such changes in chondrocytesmay lead to impaired
function. Any of these factors may be potentially damaging, because in
cartilage, in contrast with most other tissues, there are no means by
which dead or poorly performing cells can be replaced. It is this feature
that makes chondrocytes special and cartilage the tissue in the joint
most at risk of irreversible damage and loss.
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NEW GENOMIC TECHNOLOGIES FOR THE STUDY OF OA
I. Meulenbelt. LUMC, Leiden, Netherlands
Osteoarthritis (OA) is a prevalent, disabling joint disease with a consider-
able, but complex, genetic component. In order to dissect underlying
mechanisms of OA, many researchers have applied genetic genome wide
approaches or, to explore the dynamic state ofOA affected cartilage,micro
arrayRNAexpressionproﬁling. Althoughrobustﬁndingshavebeen found,
major challenges remain; current OA susceptibility SNPs explain only
a small part of the heritability, whereas, micro-array expression tech-
niques have shown to have onlya limited ability to catalogue and quantify
the transcriptome. Given the small attributable risk of current OA
susceptibility SNPs, researchers have come to the presumption that there
may be many, yet undetected, rare variants and/or unconsidered non-
genetic variation that could inﬂuence the complex etiology of OA.
The introduction of high-throughput next generation sequencing
technologies has revolutionized both genomic and transcriptomic
research. It allows whole genome and exome DNA sequencing in
addition to sensitive RNA analyses through cDNA sequencing. As such, it
eliminates a large part of the posed challenges. Considering the non-
genetic variation, especially the epigenetic variation appears to be
relevant. Epigenetic marks as reﬂected by methylation of cytosine's in
cytosine-guanine (CpG) dinucleotides are involved in processes that
require a stable control of gene expression or a selective gene-silencing.
Loss of epigenetic control may result in differential gene expression and
may underlie complex traits. Up until now, however, the studies aiming
to explore these non-genetic variations were performed with inade-
quate genome coverage or failed to measure in the relevant (diseased)
tissue. Recently for DNA methylation, a new technology has become
available that allows high throughput typing of around 500,000
metylation sites, covering around 99 percent of RefSeq genes.
Together, these new genomic technologies may provide important
additional biological insights into molecular and cellular events
commencing OA onset.
I-20
CLINICAL PAIN SEVERITY AND EXPERIMENTAL PAIN SENSITIVITY IN
OSTEOARTHRITIS
Y.C. Lee. Brigham and Women's Hosp., Boston, MA
Pain is the most common presenting symptom of osteoarthritis and an
important outcome in most osteoarthritis intervention trials. However,
the causes of pain among osteoarthritis patients are not well-under-
stood, and studies of pain mechanisms have been limited. To date, most
studies have relied on visual analog scales of overall pain or patient-
reported pain at joint sites, but these measurements are subjective and
prone to bias. Although osteoarthritis is often deﬁned structurally by
cartilage loss and joint space narrowing, population-based studies have
indicated that the association between joint space narrowing andpatient-reported pain is weak. Recent studies, however, suggest that
correlations between structural changes and pain may be masked by
other factors, such as central pain processing mechanisms, which differ
between patients. To examine pain mechanisms, some studies have
utilized quantitative sensory testing techniques, which rely on the
application of deﬁned, noxious, experimental stimuli to determine pain
threshold and tolerance levels. These studies suggest that, compared to
pain-free controls, osteoarthritis patients are more sensitive to exper-
imental noxious stimuli at both joint and non-joint sites, indicating
diffuse hyperalgesia, characteristic of central pain syndromes. Studies
using quantitative sensory testing methods and functional neuro-
imaging have also indicated that osteoarthritis patients have impair-
ments in conditioned pain modulation, also known as descending
analgesia or diffuse noxious inhibitory controls. This talk will give an
overview of the study of pain mechanisms in osteoarthritis, focusing on
studies of experimental pain sensitivity in osteoarthritis patients, and
the implications of these studies for future research and for the
development of pain management strategies in osteoarthritis.
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NEW GUIDELINES ON PUBLISHING ANIMAL STUDIES
C.B. Little. Kolling Inst. of Med. Res., Univ. of Sydney, St Leonards, Australia
Animal models are powerful research tools that provide a critical step
not only in furthering our understanding of disease pathogenesis and
potential therapeutic intervention, but also they contribute signiﬁcantly
to the “translatability” of drug discovery projects toward clinical reali-
zation. It is scientiﬁcally incumbent upon researchers to ensure that
their experiments are well designed, controlled, powered, analyzed and
reported. In the case of research involving animal models, this is true
not only from the perspective of good scientiﬁc practice but also to
fulﬁll our responsibility for the appropriate and ethical use of animals
i.e. implementing the “3Rs”. A critical component of reduction and
reﬁnement is ensuring that animal studies are appropriately planned,
evaluated, and reported. Poor reporting is as problematic as poor
experimental design in diminishing the value and validity of any
scientiﬁc research. Recent reviews have highlighted the deﬁciencies in
reporting in many studies using animal models for a variety of diseases,
and those for osteoarthritis (OA) are no exception.
The ARRIVE guidelines were developed to provide a comprehensive
checklist (20 items) for authors to follow (1), and their use is now
a recommendation for submission of such manuscripts to OA&C.
Although the emphasis is on “reporting”, the ARRIVE and other
guidelines, should be consulted BEFORE embarking on a study using
animals, to ensure researchers control for factors that can signiﬁcantly
alter the experimental outcomes, and hamper or even invalidate the
interpretation of the data. While applicable to all animal-based studies,
the present workshop will highlight and discuss the importance of the
ARRIVE guidelines as they speciﬁcally relate to OA research (2). Addi-
tionally speciﬁc issues in statistical analysis of animal studies (e.g. small
“n”, ordinal data etc) will be reviewed. In the long term, use of these
guidelines will promote more consistent publication of animal studies,
ultimately enabling better comparisons between laboratories and
systematic reviews of the literature.
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STATE OF ART IN MANAGING HAND OSTEOARTHRITIS
L. Punzi, P. Frallonardo, C. Campana, R. Ramonda. Rheumatology Unit,
Univ. of Padova, Padova, Italy
Hand osteoarthritis (HOA) is a common disorder frequently causing
pain and impaired function with subsequent reduction in health-
related quality of life. Compared to other OA localisations, the
management of HOA may be sometimes difﬁcult, due to its great
heterogeneity. The treatment may be inﬂuenced by many factors,
